Kume Shinji
Department of Medicine, Shiga University of Medical Science, Tsukinowa-cho, Seta, Otsu, 520-2192 Shiga Japan.
Diabetol Int. 2019 Aug 13;10(4):245-249. doi: 10.1007/s13340-019-00406-9. eCollection 2019 Oct.
Diabetic nephropathy, which is characterized by increased albuminuria, has been the most common cause of end-stage kidney disease for many years in Japan and many other countries. Although the renal prognosis of the disease has been improving in recent years because of the clinical implementation of strict glucose, blood pressure, and lipid controls, some diabetes patients continue to exhibit treatment-resistant macroalbuminuria leading to end-stage kidney disease. Furthermore, renal function decline without macroalbuminuria in diabetes is an emerging issue in Japan, which might be partly due to aging. Thus, a novel therapeutic strategy is needed to further improve renal outcome in diabetes patients. We have recently reported the involvement of dysregulation of intracellular nutrient-sensing signals and the related cellular process, autophagy, in the pathogenesis of diabetic nephropathy and abnormal insulin secretion pattern in type 2 diabetes. This review discusses potential roles of intracellular nutrient-sensing signals and autophagy as novel therapeutic targets for type 2 diabetes and diabetic nephropathy.
糖尿病肾病以蛋白尿增加为特征,多年来一直是日本和许多其他国家终末期肾病的最常见原因。尽管近年来由于严格控制血糖、血压和血脂的临床应用,该疾病的肾脏预后有所改善,但一些糖尿病患者仍表现出难治性大量蛋白尿,最终导致终末期肾病。此外,在日本,糖尿病患者无大量蛋白尿时的肾功能下降是一个新出现的问题,这可能部分归因于老龄化。因此,需要一种新的治疗策略来进一步改善糖尿病患者的肾脏预后。我们最近报道了细胞内营养感应信号失调及相关细胞过程自噬参与了糖尿病肾病的发病机制以及2型糖尿病异常胰岛素分泌模式的形成。本综述讨论了细胞内营养感应信号和自噬作为2型糖尿病和糖尿病肾病新治疗靶点的潜在作用。